- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02511769
Web-MAP Intervention for Youth With Sickle Cell Disease (Web-MAP)
WEB MAP Intervention for Youth With Sickle Cell Disease
The proposed study will determine whether the efficacy of WebMAP cognitive behavioral therapy (CBT) treatment study generalizes to pediatric sickle cell disease (SCD), and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment from sickle cell centers will also be determined. The short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral intervention in a large population of youth with SCD. The long-term goal of this research is to develop effective, easily accessible, behavioral pain interventions for youth with SCD to reduce the long-term impact of pain on function, quality of life, and health service use in this population.
The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in reducing pain and functional impairment in youth with sickle cell disease. (Figure 1) Subjects will be randomized to either the behavioral intervention or the online patient education control group. The treatment protocol will be implemented over 8 weeks in Internet-based treatment modules. The primary study outcome is pain and functional impairment measured at baseline, immediately post-treatment, and at 3-month follow-up.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed study will determine whether the efficacy of WebMAP generalizes to pediatric SCD, and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment from sickle cell centers will also be determined. The short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral intervention in a large population of youth with SCD. The long-term goal of this research is to develop effective, easily accessible, behavioral pain interventions for youth with SCD to reduce the long-term impact of pain on function, quality of life, and health service use in this population.
The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in reducing pain and functional impairment in youth with sickle cell disease. (Figure 1) Subjects will be randomized to either the behavioral intervention or the online patient education control group. The treatment protocol will be implemented over 8 weeks in Internet-based treatment modules. The primary study outcome is pain and functional impairment measured at baseline, immediately post-treatment, and at 3-month follow-up.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06106
- CCMC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Documented sickle cell disease (verified by physician at SCD center if referred participant is a self referral)
- 11-18 years old
- Parental/patient consent and patient assent
- Internet and computer or smartphone access
- Score of >3 on the SCPBI-Y
Exclusion Criteria:
- Primary language spoken other than English
- 11<Age≤19
- Serious comorbid chronic condition (e.g., diabetes, arthritis, cancer)
- More than 4 sessions of outpatient behavioral therapy for pain management in the 6 months prior to the time of screening
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: WEB-MAP CBT
Web-MAP Group.
Participants will have access to the full version of the web program.
They will be asked to log in to the website using their own personal computer at home, work, school, or a public library.
Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site.
The online treatment will take between 8 and 9 weeks for participants to complete.
Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation).
Adolescents and parents will be asked to complete a total of 8 modules each.
|
Web-MAP Group: Participants will have access to the full version of the web program.
They will be asked to log in to the website using their own personal computer at home, work, school, or a public library.
Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site.
The online treatment will take between 8 and 9 weeks for participants to complete.
Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation).
Adolescents and parents will be asked to complete a total of 8 modules each.
|
Active Comparator: WEB-MAP Educational Control Group
OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage.
This group will serve as an attention control condition.
Children will continue with the standard medical care that has been prescribed for their pain problem.
Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments.
This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.
|
OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage.
This group will serve as an attention control condition.
Children will continue with the standard medical care that has been prescribed for their pain problem.
Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments.
This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy in pain reduction
Time Frame: 6 months
|
We will compare pain intensity (pain scores), pain burden (Sickle Cell Pain Burden Interview), activity limitations (Child Activity Limitations Interview), quality of life (PedsQL), and health service use, and their corresponding changes from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study).
We will used a paired sample t-test.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of reducing depressive symptoms
Time Frame: 6 months
|
We will compare changes changes in depressive symptoms using the Centers for Epidemiological Study Depression scale from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study).
We will used a paired sample t-test.
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of WEB-MAP program
Time Frame: 6 months
|
We will conduct interviews with participants of the study using a script to start a dialogue on how user friendly their interface is, perceived difficulties or barriers, improvements to make, and general overall feedback to modify the program.
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: William T Zempsky, MD, MPH, Connecticut Children's Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-032
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sickle Cell Disease
-
Klein Buendel, Inc.National Institute on Minority Health and Health Disparities (NIMHD); Hilton...CompletedSickle Cell Disease | Sickle Cell Anemia in Children | Sickle Cell Thalassemia | Sickle Cell SC DiseaseUnited States
-
Nova Laboratories LimitedCompletedSickle Cell Disease | Sickle Cell Hemoglobin C | Sickle Cell-beta-thalassemia | Sickle-Cell; Hemoglobin Disease, ThalassemiaUnited Kingdom, Jamaica
-
SangartCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseUnited Kingdom, France, Jamaica, Lebanon
-
SangartWithdrawnSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseFrance, United Kingdom, Netherlands, Turkey, Bahrain, Belgium, Brazil, Lebanon, Qatar
-
University of British ColumbiaCompletedSickle Cell Disease | Beta-Thalassemia | Sickle Cell Trait | Sickle Cell-Beta Thalassemia | Sickle Cell-SS DiseaseCanada, Nepal
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Heart, Lung, and Blood Institute (NHLBI)TerminatedSickle Cell Anemia | Sickle Cell-hemoglobin C Disease | Sickle Cell-β0-thalassemiaUnited States
-
University of RegensburgRecruitingSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | HbS Disease | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SGermany, Austria
-
Centre Hospitalier Intercommunal CreteilRecruitingSickle-Cell Disease Nos With CrisisFrance
-
HemaQuest Pharmaceuticals Inc.TerminatedSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SUnited States, Lebanon, Egypt, Canada, Jamaica
-
HemaQuest Pharmaceuticals Inc.CompletedSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SUnited States, Lebanon, Canada, Egypt, Jamaica
Clinical Trials on WEB-MAP CBT
-
Seattle Children's HospitalCompletedChronic Pain | Headache | Central SensitisationUnited States
-
Seattle Children's HospitalUniversity of VirginiaActive, not recruitingMigraine Disorders | Insomnia | Headache DisordersUnited States
-
University of California, Los AngelesCompletedInsomnia ChronicUnited States
-
Syracuse VA Medical CenterNational Development and Research Institutes, Inc.CompletedSubstance Use Disorders | Stress Disorders, Post-traumaticUnited States
-
Luleå Tekniska UniversitetCounty Council of Norrbotten, SwedenUnknownMusculoskeletal PainSweden
-
Oregon Research InstituteNational Institute of Mental Health (NIMH)CompletedPostpartum DepressionUnited States, Australia
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProstate CancerUnited States
-
University of South FloridaUniversity of South FloridaRecruitingInsomnia | DementiaUnited States
-
University of California, San FranciscoCompleted
-
National Development and Research Institutes, Inc.National Institute on Drug Abuse (NIDA); Beth Israel Medical CenterCompleted